- Home
- SWK vs RGC Comparison
SWK vs RGC Comparison
Compare SWK & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SWK | RGC |
|---|---|---|
| Founded | 1843 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SWK | RGC |
|---|---|---|
| Price | $78.51 | $51.17 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $91.63 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 412.8K |
| Earning Date | 02-04-2026 | 10-24-2025 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.90 | N/A |
| Revenue | ★ $15,166,300,000.00 | N/A |
| Revenue This Year | $0.05 | N/A |
| Revenue Next Year | $2.96 | N/A |
| P/E Ratio | $27.88 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $53.91 | $0.09 |
| 52 Week High | $91.06 | $83.60 |
Technical Indicators
Market Signals| Indicator | SWK | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 62.72 | 86.96 |
| Support Level | $74.16 | $20.70 |
| Resistance Level | $75.69 | $25.50 |
| Average True Range (ATR) | 2.18 | 4.69 |
| MACD | 0.35 | 2.31 |
| Stochastic Oscillator | 71.35 | 98.07 |
Price Performance
Historical ComparisonAbout SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.